期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
2型糖尿病伴冠心病患者血糖波动及血清Gal-3对主要不良心血管事件的预测价值 被引量:11
1
作者 郭剑平 匡林华 +3 位作者 彭丹萍 符金香 郑欢欢 颜迪恩 《中国现代医学杂志》 CAS 北大核心 2022年第23期90-96,共7页
目的探讨2型糖尿病伴冠心病患者血糖波动及血清半乳糖凝集素-3(Gal-3)对主要不良心血管事件的预测价值。方法选取2019年3月—2021年3月吉安市中心人民医院收治的118例2型糖尿病伴冠心病患者和54例单纯2型糖尿病患者,另选取同期该院46例... 目的探讨2型糖尿病伴冠心病患者血糖波动及血清半乳糖凝集素-3(Gal-3)对主要不良心血管事件的预测价值。方法选取2019年3月—2021年3月吉安市中心人民医院收治的118例2型糖尿病伴冠心病患者和54例单纯2型糖尿病患者,另选取同期该院46例健康体检者。比较3组空腹血糖(FBG)、糖化血红蛋白(HbA1c)及血清Gal-3水平;比较不同病情严重程度2型糖尿病伴冠心病患者24 h血糖、血糖波动幅度及血清Gal-3水平;采用Pearson相关性分析病情严重程度与24 h血糖、血糖波动幅度及Gal-3的关系;随访1年,统计2型糖尿病伴冠心病患者主要不良心血管事件发生情况;采用单因素分析影响2型糖尿病伴冠心病患者主要不良心血管事件发生的因素,并对其影响因素进行多因素逐步Logistic回归分析;绘制受试者工作特征(ROC)曲线分析24 h血糖、血糖波动幅度及血清Gal-3预测2型糖尿病伴冠心病患者发生主要不良心血管事件的价值。结果2型糖尿病伴冠心病患者FBG、HbA1c及血清Gal-3水平较单纯2型糖尿病患者和健康体检者高(P<0.05);高危组24 h血糖、血糖波动幅度及血清Gal-3水平较中危组、低危组高(P<0.05);相关性分析结果显示,患者病情严重程度(Gensini分数)与24 h血糖、血糖波动幅度及血清Gal-3呈正相关(r=0.404、0.437和0.526,均P<0.05);随访1年,118例2型糖尿病伴冠心病患者中共有36例发生主要不良心血管事件,发生组患者2支及以上病变支数、FBG、HbA1c、24 h血糖、血糖波动幅度及血清Gal-3水平高于未发生组(P<0.05);多因素逐步Logistic回归分析结果显示,病变支数[O^R=2.821(95%CI:1.053,7.557)]、24 h血糖[O^R=3.873,(95%CI:1.446,10.376)]、血糖波动幅度[O^R=3.636(95%CI:1.357,9.742)]、Gal-3[O^R=3.442(95%CI:1.285,9.221)]是影响2型糖尿病伴冠心病患者主要不良心血管事件发生的危险因素(P<0.05);ROC曲线分析显示,2型糖尿病伴冠心病患者24 h血糖、血糖波动幅度及血清Gal-3预测主要不良心血管事件的最佳截断值分别为3.72 mmol/L、2.15 mmol/L和11.90 ng/mL,敏感性分别为83.33%(95%CI:0.672,0.936)、80.56%(95%CI:0.640,0.918)和86.11%(95%CI:0.705,0.953),特异性分别为76.83%(95%CI:0.662,0.854)、65.85%(95%CI:0.546,0.760)和63.41%(95%CI:0.522,0.738),曲线下面积(AUC)分别为0.840(95%CI:0.761,0.901)、0.775(95%CI:0.689,0.847)和0.813(95%CI:0.731,0.879),三者联合预测的敏感性、特异性及AUC分别为80.56%(95%CI:0.640,0.918)、97.56%(95%CI:0.915,0.997)和0.949(95%CI:0.892,0.981)。结论2型糖尿病伴冠心病患者血糖波动及血清Gal-3影响主要不良心血管事件的发生,两者均可作为预测主要不良心血管事件的敏感指标。 展开更多
关键词 2型糖尿病 冠心病 血糖波动 血清半乳糖凝集素-3 主要不良心血管事件
下载PDF
Impact of body mass index on the development of pocket hematoma:A retrospective study in Chinese people 被引量:2
2
作者 jian-ping guo Zhao-Liang SHAN +4 位作者 Hong-Yang guo Hong-Tao YUAN Kun LIN Yue-Xiang ZHAO Yu-Tang WANG 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2014年第3期212-217,共6页
BackgroundPocket hematoma is one of the major complications associated with cardiovascular implantable electronic devices (CIEDs) implantation. The aim of this study is to evaluate the impact of body mass index (BM... BackgroundPocket hematoma is one of the major complications associated with cardiovascular implantable electronic devices (CIEDs) implantation. The aim of this study is to evaluate the impact of body mass index (BMI) on the occurrence of pocket hematoma after CIEDs implantation.MethodsThe study is a retrospective review of 972 patients receiving CIEDs implantation between 2008 and 2012 in a tertiary hospital.ResultsTwenty two patients (2.2%) developed severe pocket hematoma requiring re-intervention. The hematoma rate (4.6%,n = 15) of patients with a BMI of 〈 23 kg/m2 was significantly higher compared with that of patients with a BMI of≥23 kg/m2 (1.1%, n = 7,P〈 0.001). In multivariate regression analysis, a BMI 〈 23.0 kg/m2 may be associated with the development of severe pocket hema-toma. An increase of 1.0 kg/m2 in BMI was associated with lower incidence of hematoma formation (OR: 0.84; 95% CI: 0.74-0.95;P = 0.006).ConclusionBMI 〈 23 kg/m2 was associated with a higher incidence of pocket hematoma, requiring re-intervention. The data sup-port that great care must be taken when patients were with a lower BMI received CIEDs implantation. 展开更多
关键词 Hematoma Pacemaker Body mass index Complication
下载PDF
ILIF7 Gene Polymorphism Is not Associated with Rheumatoid Arthritis Susceptibility in the Northern Chinese Han Population: A Case-Control Study 被引量:3
3
作者 Xiao-Ying Zhang Yu Zuo +5 位作者 Chun Li Xin TU Hu-Ji Xu jian-ping guo Zhan-guo Li Rong Mu 《Chinese Medical Journal》 SCIE CAS CSCD 2018年第2期171-179,共9页
Background: Interleukin (IL)-37, also called ILl F7, is a natural inhibitor of inflammatory and immune responses. It is involved in the pathogenesis of rheumatoid arthritis (RA). This study aimed to investigate t... Background: Interleukin (IL)-37, also called ILl F7, is a natural inhibitor of inflammatory and immune responses. It is involved in the pathogenesis of rheumatoid arthritis (RA). This study aimed to investigate the role oflL1F7 gene polymorphism in RA susceptibility in a large cohort of patients. Methods: Five selected single-nucleotide polynaorphisms in IL 1F7 genes (rs2723186, rs3811046, rs4241122, rs4364030, and rs4392270) were genotyped by TaqMan Allelic Discrimination in Northern Chinese Han population. The allele and the genotype were compared between patients with RA and healthy controls. Association analyses were performed on the entire data set and on different RA subsets based on the status of the anti-cyclic citrullinated peptide antibody and the rheumatoid factor by logistic regression, adjusting for age and gender. Results: Trend associations were detected between rs2723186, rs4241122, rs4392270, and RA in Stage I (160 patients with RA: 252 healthy controls). Further validation in Stage II comprised 730 unrelated patients with RA (mean age: 54.9 ± 12.6 years; 81.6% females) and 778 unrelated healthy individuals (mean age: 53.5 ± 15.7 years; 79.5% females). No significant differences in the distributions of alleles and genotypes were observed between the case and control groups in both the entire set and the different RA subsets. Disease activity and age of RA onset were also not associated with genotype distributions. Conclusion: 1L1F7 gene polymorphism does not significantly influence RA susceptibility in the Northern Chinese Hart population. 展开更多
关键词 ILIF7 Gene lnterleukin-37 Rheumatoid Arthritis Single-nucleotide Polymorphisms
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部